Literature DB >> 20628503

A critical appraisal of treatments for bipolar disorder.

Andrew A Nierenberg1.   

Abstract

Recovery-the absence of all abnormal mood symptoms-is the goal of treatment for bipolar disorder. Unfortunately, a minority of people suffering from bipolar disorder achieve sustained recovery. Improving recovery rates for this population will require clinicians in the primary care setting to be familiar with appropriate treatments for acute bipolar mania and depression and for the maintenance phase. Efficacy and tolerability of pharmacotherapeutic and psychotherapeutic options for all phases of treatment and each type of mood episode are discussed. Primary care physicians are encouraged to avoid prescribing antidepressant monotherapy for any patient with depression and a history of mania or hypomania.

Entities:  

Year:  2010        PMID: 20628503      PMCID: PMC2902191          DOI: 10.4088/PCC.9064su1c.04

Source DB:  PubMed          Journal:  Prim Care Companion J Clin Psychiatry        ISSN: 1523-5998


  38 in total

Review 1.  Consensus development conference on antipsychotic drugs and obesity and diabetes.

Authors: 
Journal:  J Clin Psychiatry       Date:  2004-02       Impact factor: 4.384

2.  A placebo-controlled evaluation of adjunctive modafinil in the treatment of bipolar depression.

Authors:  Mark A Frye; Heinz Grunze; Trisha Suppes; Susan L McElroy; Paul E Keck; Jorge Walden; Gabriele S Leverich; Lori L Altshuler; Shoshanna Nakelsky; Sun Hwang; Jim Mintz; Robert M Post
Journal:  Am J Psychiatry       Date:  2007-08       Impact factor: 18.112

3.  Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial.

Authors:  Mauricio Tohen; Waldemar Greil; Joseph R Calabrese; Gary S Sachs; Lakshmi N Yatham; Bruno Müller Oerlinghausen; Athanasios Koukopoulos; Giovanni B Cassano; Heinz Grunze; Rasmus W Licht; Liliana Dell'Osso; Angela R Evans; Richard Risser; Robert W Baker; Heidi Crane; Martin R Dossenbach; Charles L Bowden
Journal:  Am J Psychiatry       Date:  2005-07       Impact factor: 18.112

4.  A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group.

Authors:  J R Calabrese; C L Bowden; G S Sachs; J A Ascher; E Monaghan; G D Rudd
Journal:  J Clin Psychiatry       Date:  1999-02       Impact factor: 4.384

5.  Exploring the risk of diabetes mellitus and dyslipidemia among ambulatory users of atypical antipsychotics: a population-based comparison of risperidone and olanzapine.

Authors:  Jocelyne Moisan; Jean-Pierre Grégoire; Michel Gaudet; Dan Cooper
Journal:  Pharmacoepidemiol Drug Saf       Date:  2005-06       Impact factor: 2.890

Review 6.  Antidepressants for bipolar depression: a systematic review of randomized, controlled trials.

Authors:  Harm J Gijsman; John R Geddes; Jennifer M Rendell; Willem A Nolen; Guy M Goodwin
Journal:  Am J Psychiatry       Date:  2004-09       Impact factor: 18.112

7.  A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes.

Authors:  Richard H Weisler; Amir H Kalali; Terence A Ketter
Journal:  J Clin Psychiatry       Date:  2004-04       Impact factor: 4.384

8.  Aripiprazole monotherapy for maintenance therapy in bipolar I disorder: a 100-week, double-blind study versus placebo.

Authors:  Paul E Keck; Joseph R Calabrese; Roger S McIntyre; Robert D McQuade; William H Carson; James M Eudicone; Berit X Carlson; Ronald N Marcus; Raymond Sanchez
Journal:  J Clin Psychiatry       Date:  2007-10       Impact factor: 4.384

9.  Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group.

Authors:  C L Bowden; A M Brugger; A C Swann; J R Calabrese; P G Janicak; F Petty; S C Dilsaver; J M Davis; A J Rush; J G Small
Journal:  JAMA       Date:  1994 Mar 23-30       Impact factor: 56.272

10.  A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder.

Authors:  Joseph R Calabrese; Charles L Bowden; Gary Sachs; Lakshmi N Yatham; Kirsten Behnke; Olli-Pekka Mehtonen; Paul Montgomery; John Ascher; Walter Paska; Nancy Earl; Joseph DeVeaugh-Geiss
Journal:  J Clin Psychiatry       Date:  2003-09       Impact factor: 4.384

View more
  3 in total

1.  The role of primary care clinicians in diagnosing and treating bipolar disorder.

Authors:  Larry Culpepper
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2010

2.  Amphetamine-induced appetitive 50-kHz calls in rats: a marker of affect in mania?

Authors:  Marcela Pereira; Roberto Andreatini; Rainer K W Schwarting; Juan C Brenes
Journal:  Psychopharmacology (Berl)       Date:  2014-01-11       Impact factor: 4.530

Review 3.  Tamoxifen use for the management of mania: a review of current preclinical evidence.

Authors:  Fernanda Armani; Monica Levy Andersen; José Carlos Fernandes Galduróz
Journal:  Psychopharmacology (Berl)       Date:  2014-01-18       Impact factor: 4.530

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.